| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 23 |
| 1 | ASPIRIN | 17 |
| 2 | ASPIRIN 325 MG | 16 |
| 3 | ASPIRIN 81 MG | 16 |
| 4 | CARBOPLATIN | 15 |
| 5 | DEXAMETHASONE | 15 |
| 6 | DEXAMETHASONE 1.5 MG | 15 |
| 7 | PEMBROLIZUMAB | 14 |
| 8 | ALBUTEROL SULFATE | 11 |
| 9 | PACLITAXEL | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVAMLODIPINE | 1 | 0.0080 |
| 1 | LISOCABTAGENE MARALEUCEL | 2 | 0.0023 |
| 2 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 6 | 0.0013 |
| 4 | MITOTANE | 2 | 0.0011 |
| 5 | HYDROCORTISONE SODIUM SUCCINATE | 4 | 0.0010 |
| 6 | CEMIPLIMAB-RWLC | 2 | 0.0010 |
| 7 | DEFLAZACORT | 2 | 0.0008 |
| 8 | ARGATROBAN | 1 | 0.0007 |
| 9 | MANNITOL | 3 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 31 |
| 1 | Loop Diuretic [EPC] | 23 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 23 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 4 | Platinum-based Drug [EPC] | 21 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 17 |
| 6 | Osmotic Laxative [EPC] | 16 |
| 7 | Proton Pump Inhibitor [EPC] | 13 |
| 8 | Microtubule Inhibitor [EPC] | 11 |
| 9 | Calcium Channel Blocker [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 4 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 5 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 6 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 7 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Cannabinoid [EPC] | 2 | 0.0002 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 23 | 0.0002 |